Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 (2021)
Source: New england journal of medicine. Unidade: FM
Subjects: COVID-19, TROMBOSE, ANTICOAGULANTES
ABNT
GOLIGHER, Ewan C et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New england journal of medicine, v. 385, n. 9, p. 777-789, 2021Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2103417. Acesso em: 15 nov. 2024.APA
Goligher, E. C., Bradbury, C. A., Mcverry, B. J., Lawler, P. R., Berger, J. S., Gong, M. N., et al. (2021). Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New england journal of medicine, 385( 9), 777-789. doi:10.1056/NEJMoa2103417NLM
Goligher EC, Bradbury CA, Mcverry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Nicolau JC. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 777-789.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa2103417Vancouver
Goligher EC, Bradbury CA, Mcverry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Nicolau JC. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 777-789.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1056/NEJMoa2103417